Intestinal dysbiosis: Novel mechanisms by which gut microbes trigger and prevent disease

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

New research has identified specific intestinal colonizing microbes that can have significant influence on health and disease. Evidence is reviewed supporting an association between Fusobacterium nucleatum and colon cancer and for a protective role of Faecalibacterium prausnitzii in inflammatory bowel disease, of Escherichia coli Nissle 1917 in acute intestinal inflammation, of Bifidobacterium infantis in neonatal necrotizing enterocolitis, and of Akkermansia muciniphila in obesity and diabetes. These novel bacteria are clinically relevant and present opportunities for more focused diagnosis of colon cancer and prevention of common diseases.

Original languageEnglish (US)
Pages (from-to)133-137
Number of pages5
JournalPreventive Medicine
Volume65
DOIs
StatePublished - 2014

Fingerprint

Dysbiosis
Colonic Neoplasms
Fusobacterium nucleatum
Necrotizing Enterocolitis
Inflammatory Bowel Diseases
Obesity
Escherichia coli
Inflammation
Bacteria
Health
Research

Keywords

  • Acute intestinal inflammation
  • Akkermansia muciniphila
  • Bifidobacterium infantis
  • Colon cancer
  • Escherichia coli Nissle 1917
  • Faecalibacterium prausnitzii
  • Fusobacterium nucleatum
  • Inflammatory bowel disease
  • Necrotizing enterocolitis
  • Obesity

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Intestinal dysbiosis : Novel mechanisms by which gut microbes trigger and prevent disease. / Underwood, Mark.

In: Preventive Medicine, Vol. 65, 2014, p. 133-137.

Research output: Contribution to journalArticle

@article{e087766195424e1993917f44af679c14,
title = "Intestinal dysbiosis: Novel mechanisms by which gut microbes trigger and prevent disease",
abstract = "New research has identified specific intestinal colonizing microbes that can have significant influence on health and disease. Evidence is reviewed supporting an association between Fusobacterium nucleatum and colon cancer and for a protective role of Faecalibacterium prausnitzii in inflammatory bowel disease, of Escherichia coli Nissle 1917 in acute intestinal inflammation, of Bifidobacterium infantis in neonatal necrotizing enterocolitis, and of Akkermansia muciniphila in obesity and diabetes. These novel bacteria are clinically relevant and present opportunities for more focused diagnosis of colon cancer and prevention of common diseases.",
keywords = "Acute intestinal inflammation, Akkermansia muciniphila, Bifidobacterium infantis, Colon cancer, Escherichia coli Nissle 1917, Faecalibacterium prausnitzii, Fusobacterium nucleatum, Inflammatory bowel disease, Necrotizing enterocolitis, Obesity",
author = "Mark Underwood",
year = "2014",
doi = "10.1016/j.ypmed.2014.05.010",
language = "English (US)",
volume = "65",
pages = "133--137",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Intestinal dysbiosis

T2 - Novel mechanisms by which gut microbes trigger and prevent disease

AU - Underwood, Mark

PY - 2014

Y1 - 2014

N2 - New research has identified specific intestinal colonizing microbes that can have significant influence on health and disease. Evidence is reviewed supporting an association between Fusobacterium nucleatum and colon cancer and for a protective role of Faecalibacterium prausnitzii in inflammatory bowel disease, of Escherichia coli Nissle 1917 in acute intestinal inflammation, of Bifidobacterium infantis in neonatal necrotizing enterocolitis, and of Akkermansia muciniphila in obesity and diabetes. These novel bacteria are clinically relevant and present opportunities for more focused diagnosis of colon cancer and prevention of common diseases.

AB - New research has identified specific intestinal colonizing microbes that can have significant influence on health and disease. Evidence is reviewed supporting an association between Fusobacterium nucleatum and colon cancer and for a protective role of Faecalibacterium prausnitzii in inflammatory bowel disease, of Escherichia coli Nissle 1917 in acute intestinal inflammation, of Bifidobacterium infantis in neonatal necrotizing enterocolitis, and of Akkermansia muciniphila in obesity and diabetes. These novel bacteria are clinically relevant and present opportunities for more focused diagnosis of colon cancer and prevention of common diseases.

KW - Acute intestinal inflammation

KW - Akkermansia muciniphila

KW - Bifidobacterium infantis

KW - Colon cancer

KW - Escherichia coli Nissle 1917

KW - Faecalibacterium prausnitzii

KW - Fusobacterium nucleatum

KW - Inflammatory bowel disease

KW - Necrotizing enterocolitis

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84901491205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901491205&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2014.05.010

DO - 10.1016/j.ypmed.2014.05.010

M3 - Article

C2 - 24857830

AN - SCOPUS:84901491205

VL - 65

SP - 133

EP - 137

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -